Dow Inc.

Dow Inc. is one of the world's largest materials science companies, producing the chemical building blocks — ethylene, polyethylene, propylene oxide, silicones, acrylics — that become packaging, insulation, coatings, adhesives, and consumer products, generating $39,968 million in revenue in fiscal 2025. Dow operates 29 manufacturing sites globally, employs approximately 34,600 people, and sits at the center of a supply chain that touches virtually every industrial and consumer end-market.

This is a story about a premier industrial franchise navigating the deepest down-cycle in a generation. In 2025, Dow posted its first annual net loss since the 2019 separation from DowDuPont, wrote down $1.9 billion in restructuring and impairment charges, cut its dividend in half, and saw both S&P and Moody's downgrade its credit to the lowest investment-grade rung. Yet the company simultaneously launched its most ambitious self-help program — Transform to Outperform, targeting $2 billion in incremental EBITDA by the end of 2027 — while retaining a feedstock-advantaged asset base, a global footprint no competitor can easily replicate, and balance-sheet liquidity of roughly $14 billion. The file turns on a deceptively simple question: can Dow's cost structure and portfolio actions outrun the industry overcapacity that is steadily compressing its margins?

The second quarter of 2026, reported on the day of this writing, offered a glimpse of what the other side could look like: $2.3 billion in Operating EBITDA on $12.1 billion of sales, driven by polyethylene pricing power and the early fruits of restructuring. But management's own third-quarter guide of $1.7 billion makes clear that one good quarter does not settle the debate. This is a cyclical business at a cyclical trough with a management team betting that self-help can bridge the gap — and the next twelve months will reveal whether the bet pays off.